Have a personal or library account? Click to login
Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes Cover

Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes

Endocrine Regulations
Volume 59 (2025): Issue 1 (January 2025)
By: Tamara Kuchmerovska,  Lesya Yanitska,  Oksana Horkunenko,  Tetiana Tykhonenko,  Liliya Kalachniuk and  Irina Pryvrotska  
Open Access
|Dec 2025
DOI: https://doi.org/10.2478/enr-2025-0028 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 244 - 254
Published on: Dec 12, 2025
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
type 2 diabetes mellitus,
coagulation,
heart,
NAD+,
NAD+/NADH ratio,
mitochondria-targeted compounds
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2025 Tamara Kuchmerovska, Lesya Yanitska, Oksana Horkunenko, Tetiana Tykhonenko, Liliya Kalachniuk, Irina Pryvrotska, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 59 (2025): Issue 1 (January 2025)Next article